Apyx Medical Corporation

Historical 13F Holders

Symbol
APYX
CUSIP
03837C106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03837C106 since 12/18/2024, newest first.

Filer % of Class Filed
Royce & Associates LP 13G/A Amendment 4 7.8% 7/21/2026
Event 6/30/2026
Nantahala Capital Management, LLC 13G/A Amendment 1
10.0% 2/13/2026
Event 12/31/2025
Royce & Associates LP 13G/A Amendment 3 6.0% 1/20/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G
10.0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 70 24.6 M $111 M
2026 Q1 68 20.8 M $76.8 M
2025 Q4 63 19.1 M $66.9 M
2025 Q3 50 15.7 M $33.7 M
2025 Q2 43 15.8 M $35.6 M
2025 Q1 47 15.8 M $21.6 M
2024 Q4 46 15.9 M $25.2 M
2024 Q3 51 12.8 M $15.9 M
2024 Q2 56 13.1 M $17.6 M
2024 Q1 59 13.4 M $18.2 M
2023 Q4 68 17.8 M $46.5 M
2023 Q3 66 18.3 M $58.7 M
2023 Q2 60 18.8 M $94.4 M
2023 Q1 58 20.1 M $58.2 M
2022 Q4 55 18.3 M $42.8 M
2022 Q3 57 20.9 M $94.0 M
2022 Q2 69 21.1 M $124 M
2022 Q1 73 19.6 M $128 M
2021 Q4 76 19.1 M $245 M
2021 Q3 75 18.9 M $261 M
2021 Q2 74 19.1 M $197 M
2021 Q1 70 19.0 M $183 M
2020 Q4 67 18.9 M $136 M
2020 Q3 62 17.8 M $83.9 M
2020 Q2 65 18.2 M $101 M
2020 Q1 70 18.1 M $65.0 M
2019 Q4 71 18.6 M $158 M
2019 Q3 70 17.8 M $120 M
2019 Q2 72 17.4 M $117 M
2019 Q1 79 15.3 M $96.7 M
2018 Q4 2 925 k $5.99 M